Enantiomer of the novel flexible heteroarotinoid, SL-1-09, blocks cell cycle progression in breast cancer cells

Emily Ginn, Jihyun Baek, Maryam Fallatah, Shengquan Liu, Mary B. Sevigny, Maggie Louie

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
Article number172634
JournalEuropean Journal of Pharmacology
Volume862
DOIs
StatePublished - 2019

Funding

This work was supported by grant funding from Dominican University, School of Health and Natural Sciences Research grant to M.C.L. and Touro University-CA, College of Pharmacy Intramural Research Award Program (IRAP) to S.L.

FundersFunder number
Dominican University of California
Touro University, California

    ASJC Scopus Subject Areas

    • Pharmacology

    Keywords

    • ER+
    • HER2
    • Breast Cancer
    • Heteroarotinoid
    • SHetA2
    • Breast cancer

    Disciplines

    • Biochemistry

    Cite this